Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,311 | 11,317 | 9,484 | 11,915 | 20,772 |
| Marketable Securities | N/A | 8,636 | 11,424 | 14,698 | 10,291 |
| Receivables | 3,155 | 3,950 | 4,072 | 3,693 | 3,330 |
| Inventories | 1,819 | 1,456 | 794 | 716 | 76 |
| Other current assets | 1,304 | 0 | 0 | 0 | 0 |
| TOTAL | $21,589 | $25,359 | $25,774 | $31,022 | $34,469 |
| Non-Current Assets | |||||
| PPE Net | 1,804 | 1,562 | 1,650 | 1,796 | 2,455 |
| Investments And Advances | 94 | 134 | 130 | 133 | 28 |
| Intangibles | 12,195 | 12,440 | 12,685 | 12,924 | 13,169 |
| Other Non-Current Assets | 4,182 | 619 | 729 | 905 | 980 |
| TOTAL | $18,275 | $14,755 | $15,194 | $15,758 | $16,632 |
| Total Assets | $39,864 | $40,114 | $40,968 | $46,780 | $51,101 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,307 | 2,356 | 1,773 | 2,005 | 2,804 |
| Accrued Expenses | 1,869 | 2,289 | 2,333 | 2,432 | 2,537 |
| Other current liabilities | 13,570 | 17,484 | 681 | 561 | 388 |
| TOTAL | $18,695 | $23,288 | $5,893 | $6,129 | $6,944 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 360 | 742 | 548 | 416 | 362 |
| Other Non-Current Liabilities | 6,673 | 5,006 | 15,457 | 14,848 | 15,815 |
| TOTAL | $6,331 | $4,588 | $15,135 | $15,268 | $15,472 |
| Total Liabilities | $25,026 | $27,876 | $21,028 | $21,397 | $22,416 |
| Shareholders' Equity | |||||
| Common Shares | 363 | 301 | 287 | 286 | 286 |
| Retained earnings | -274,071 | -274,498 | -266,868 | -261,449 | -257,586 |
| Other shareholders' equity | 16,289 | 16,581 | 16,873 | 17,094 | 16,632 |
| TOTAL | $14,838 | $12,238 | $19,940 | $25,383 | $28,685 |
| Total Liabilities And Equity | $39,864 | $40,114 | $40,968 | $46,780 | $51,101 |